Matthew G Digiovanni

Matthew G Digiovanni

Touro College - New York / United States
Others
AD Scientific Index ID: 4802622
person_outline Matthew G Digiovanni's MOST POPULAR ARTICLES
1-) A novel tricarbonylmethane agent (CMC2. 24) reduces human pancreatic tumor growth in mice by targeting RasNA Mallangada, JM Vargas, S Thomas, MG DiGiovanni, BM Vaeth, ...Molecular carcinogenesis 57 (9), 1130-1143, 2018162018
2-) Phospho-valproic acid (MDC-1112) reduces pancreatic cancer growth in patient-derived tumor xenografts and KPC mice: enhanced efficacy when combined with gemcitabineD Luo, MG DiGiovanni, R Wei, JF LaComb, JL Williams, B Rigas, ...Carcinogenesis 41 (7), 927-939, 202072020
3-) The C1q and gC1qR axis as a novel checkpoint inhibitor in cancerB Ghebrehiwet, M Zaniewski, A Fernandez, M DiGiovanni, TN Reyes, P Ji, ...Frontiers in Immunology 15, 1351656, 20242024
4-) F10 and 5-fluorouracil: Chemotherapeutic potential of F10 in alleviating colon cancer racial health disparityS Thaker, WH Gmeiner, P Ji, J Zabaleta, T Reyes, M DiGiovanni, X Wang, ...Cancer Research 80 (16_Supplement), 1842-1842, 20202020
5-) Abstract B076: The effect of C1q and gC1qR in breast cancer: Racial health disparitiesTN Reyes, MG Digiovanni, JL Williams, B GhebrehiwetCancer Epidemiology, Biomarkers & Prevention 29 (6_Supplement_2), B076-B076, 20202020